DCT Value Realized

Time to scale up your global DCT enterprise adoption strategy

At this years’ Clinical Operations Partnerships Select event, MaryAnne Rizk (Medable) sits down with Bryan Hill (Cognizant) to discuss practical insights on how decentralized components can be globally adopted and scaled to drive faster study start up and better patient engagement.

Attendees will hear discussions around:

  • Seamlessly incorporating DCT elements in their study designs
  • Maximizing patient success by combining core DCT technologies with direct-to-patient services
  • Unlocking valuable insights with partner ecosystems for hybrid to fully decentralized clinical trials

Not attending this year? Reach out to us today to start a conversation on how to successfully incorporate DCT elements into your organization.

MaryAnne Rizk is a Chief Strategy Officer at Medable.

Vice President, Digital Health & Innovation, Chief Technology Officer, Cognizant Life Sciences.

Save the Date!
On Demand Webinar